MarketPeel
Insider Trading Intelligence
Pricing
…
GF

Gregory Gene Freitag

AXGN
GENERAL COUNSEL · AXOGEN, INC. · CIK 0001492710
FILING MIX · LIFETIME54%/46%
BUYS
38
SELLS
33
TOTAL VALUE
$5.16M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
338,374
AVG SELL PX
$9.72
TRADE KIND
SHOWING 71 / 71
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gregory Gene Freitag, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+43.75%+0.01%+0.69%-0.68%-4.09%—
14d16+50.00%+0.02%+1.30%-1.28%-2.44%—
30d16+56.25%-2.49%+1.11%-3.60%-4.95%—
60d16+43.75%+0.28%+0.93%-0.64%-3.88%—
90d16+68.75%-4.54%+2.99%-7.53%-8.04%—
180d16+62.50%-8.14%+8.41%-16.55%-12.91%—
1y16+75.00%-32.74%+17.63%-50.37%-62.34%—
2y16(2 pending)+35.71%+7.70%+31.91%-24.20%-43.72%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AXGN · 283,498 shares · as of Jun 4, 2024
0110,453220,906331,358441,8112021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 38 buys / 33 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
54,876——54,876Jan 12, 2026Mar 3, 2026 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
22,700——22,700Jun 11, 2025Jun 11, 2025 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
15,060——15,060Feb 28, 2025Mar 3, 2025 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
15,060$1.66$25.0K61,213Feb 28, 2025Mar 3, 2025 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 24, 2024Jun 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
11,904——0Jun 4, 2024Jun 6, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
11,904——283,498Jun 4, 2024Jun 6, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
25,000$9.00$225.0K271,594Mar 7, 2024Mar 8, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
11,904——11,904Sep 1, 2023Sep 6, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
20,436——20,436Sep 1, 2023Sep 6, 2023 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jul 14, 2023Jul 17, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
6,459——296,594Jun 1, 2023Jun 5, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
6,459——0Jun 1, 2023Jun 5, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
12,500$8.65$108.1K319,615Jun 1, 2023Jun 5, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
29,480$8.74$257.7K290,135Jun 1, 2023Jun 5, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
2,828$9.17$25.9K336,755May 23, 2023May 24, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
4,640$9.26$43.0K332,115May 23, 2023May 24, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
13,000$12.74$165.6K339,583Nov 14, 2022Nov 16, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
13,000$12.50$162.5K352,583Nov 8, 2022Nov 10, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
8,886$9.70$86.2K365,583Aug 10, 2022Aug 11, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
13,046$10.37$135.3K374,469Aug 8, 2022Aug 8, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
24,000$10.64$255.4K387,515Aug 4, 2022Aug 8, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
83,000$3.38$280.5K441,811Jul 25, 2022Jul 26, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
30,296$9.26$280.5K411,515Jul 25, 2022Jul 26, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
83,000——0Jul 25, 2022Jul 26, 2022 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 28, 2022Jun 29, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
6,459——6,459Jun 1, 2022Jun 3, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
3,036——0Jun 1, 2022Jun 3, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
3,036——358,811Jun 1, 2022Jun 3, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
11,811——11,811Jun 1, 2022Jun 3, 2022 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 17, 2021Jun 17, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
9,250——0Jun 17, 2021Jun 21, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
9,250$19.17$177.3K364,556Jun 17, 2021Jun 21, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
8,781$20.92$183.7K355,775Jun 17, 2021Jun 21, 2021 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
5,882$8.50$50.0K46,153Jun 15, 2021Jun 17, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
24,000$3.67$88.1K355,306Jun 4, 2021Jun 8, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
24,000$3.67$88.1K0Jun 4, 2021Jun 8, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
3,036——3,036Jun 1, 2021Jun 3, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
6,030——6,030Jun 1, 2021Jun 3, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
50,000$8.95$447.5K0May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
15,000$5.45$81.8K0May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
15,000$5.45$81.8K281,306May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
6,000$5.45$32.7K266,306May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
9,000$5.09$45.8K260,306May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
50,000$8.95$447.5K331,306May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
22,954$3.67$84.2K0May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
6,000$5.45$32.7K0May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
22,954$3.67$84.2K251,306May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
9,000$5.09$45.8K0May 26, 2021May 28, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
24,000$22.06$529.4K228,352Feb 25, 2021Mar 1, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
1,032$18.70$19.3K251,113Feb 17, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
545$18.70$10.2K252,352Feb 17, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
3,377——252,145Feb 16, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,784——252,897Feb 16, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
916$17.81$16.3K248,345Dec 29, 2020Dec 30, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
2,300——249,261Dec 27, 2020Dec 30, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
379$16.42$6.2K245,076Dec 21, 2020Dec 22, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
925——245,455Dec 18, 2020Dec 22, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
13,046$3.67$47.9K244,530Sep 15, 2020Sep 17, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
9,000——24,000Sep 15, 2020Sep 17, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
4,046——22,954Sep 15, 2020Sep 17, 2020 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 23, 2020Jun 25, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
General Counsel
125,000$3.50$437.5K231,484May 29, 2020May 31, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
General Counsel
125,000——0May 29, 2020May 31, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Mar 16, 2020Mar 18, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Mar 16, 2020Mar 18, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
General Counsel
1,002$14.68$14.7K105,230Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,783——107,013Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
3,377——106,232Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
General Counsel
529$14.68$7.8K106,484Feb 18, 2020Feb 20, 2020 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
38,400$1.30$49.9K40,271Feb 14, 2020Feb 19, 2020 ↗View →
Other insiders · AXGN
Loading peer insiders…
About this filer
CIK 0001492710
ROLE
General Counsel
PRIMARY
AXGN
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001492710DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback